Search clinical trials for: capecitabine toxicity

Total 3571 results

Sun Yat-sen University

Recruiting

Induction Immuno-chemotherapy and Concurrent Chemoradiotherapy With or Without Apatinib in Unresectable, Locally Advanced Esophageal Squamous Cell Carcinoma

Efficacy | Toxicity | Esophageal Squamous Cell Carcinoma

China
Cancer Institute and Hospital, Chinese Academy...

Recruiting

Safety Assessment of Concurrent Radiotherapy and Novel Systemic Therapy for Breast Cancer (RADIOCOM)

Chemotherapeutic Toxicity | Radiotherapy; Complications | PARP Inhibitor | Immune Checkpoint Inhibitor | Trastuzumab | Breast Cancer, Familial Male | CDK4/6 Inhibitor | Pertuzumab

China
University of Cincinnati

Recruiting

REDEL Trial: Reduced Elective Nodal Dose for Anal Cancer Toxicity Mitigation (REDEL)

Anal Cancer

United States
Academisch Medisch Centrum - Universiteit van Amsterdam...
Servier

Recruiting

Liposomal iRInotecan, Carboplatin or oXaliplatin for Esophagogastric Cancer (LyRICX)

Esophageal Cancer

Netherlands
University of Chicago
National Institutes of Health (NIH); Translational Breast Cancer Research Consortium

Active, not recruiting

Investigation of Genetic Determinants of Capecitabine Toxicity

Breast Cancer

United States
Tyme, Inc

Completed

A Randomized Phase 2/3 Multi-Center Study of SM-88 in Patients With Metastatic Pancreatic Cancer

Pancreatic Cancer

United States
Peking University Cancer Hospital & Institute

Completed

Total Neoadjuvant Induction and Consolidation CapeOX Plus IMRT With Capecitabine for MRI Defined High-risk Rectal Cancer

Rectal Cancer

China
Hospices Civils de Lyon

Completed

Fluoropyrimidine Tailored-dose Based on Uracil Concentration in Patients Treated for Digestive Carcinomas: Evaluation of Clinical Practice (URACILMPACT)

Digestive Carcinoma

France
University of California, San Francisco
Hoffmann-La Roche

Terminated

Nicotine Patches in Reducing Hand-Foot Syndrome in Patients Who Are Receiving Capecitabine For Metastatic Breast Cancer

Breast Cancer | Palmar-plantar Erythrodysesthesia | Chemotherapeutic Agent Toxicity

United States
NovoCure GmbH
Zai Lab (Shanghai) Co., Ltd.

Unknown

Effect of Tumor Treating Fields (TTFields, 150 kHz) Concomitant With Chemotherapy as First Line Treatment of Unresectable Gastroesophageal Junction or Gastric Adenocarcinoma

Gastric Cancer | GastroEsophageal Cancer

Hong Kong
National Cancer Institute, Egypt

Completed

Study of Metronomic Capecitabine and Oxaliplatin Versus XELOX in Egyptian Metastatic Colorectal Cancer Patients

Toxicity | Survival | Clinical Response
AHS Cancer Control Alberta

Terminated

Thymidylate Synthase Polymorphisms as a Predictor of Toxicity to Capecitabine Chemotherapy in Colon Cancer Treatment

Colon Cancer

Canada
The Affiliated Nanjing Drum Tower Hospital of Nanjing...

Unknown

Intraperitoneal and System Chemotherapy Versus XELOX as First-line Chemotherapy for mCRC

Colorectal Cancer Metastatic | Chemotherapy Effect | Chemotherapeutic Toxicity

China
Newcastle-upon-Tyne Hospitals NHS Trust
University of Newcastle Upon-Tyne

Unknown

Association of Capecitabine Pharmacokinetics and Toxicity With Aging

Breast Cancer | Colorectal Cancer
Dutch Colorectal Cancer Group
Nordic Pharma SAS

Completed

S-1 Versus Capecitabine in the First Line Treatment of MCC Patients. (SALTO)

Colorectal Cancer | Metastases

Netherlands
M.D. Anderson Cancer Center
Myrexis Inc.

Completed

Association of Dihydropyrimidine Dehydrogenase (DPYD) Variants With Toxicity Related to Capecitabine

Breast Cancer

United States
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Pyridoxine and Topical Urea/Lactic Acid-Based Cream in Preventing Hand-Foot Syndrome in Patients Receiving Capecitabine for Breast Cancer or Other Cancer

Breast Cancer | Unspecified Adult Solid Tumor, Protocol Specific | Drug/Agent Toxicity by Tissue/Organ

United States
Basque Health Service

Unknown

MARY DUOL REPAIR BALM IN THE PREVENTION OR REDUCING ANTINEOPLASIC AGENTS' SKIN TOXICITY (B-DUOL)

Dermatitis, Adverse Drug Reaction

Spain
University of Pittsburgh
Genentech, Inc.

Completed

Safety and Efficacy Study Using Bevacizumab, Capecitabine and Oxaliplatin for Colorectal Cancer

Cancer

United States
National Health Research Institutes, Taiwan
Mackay Memorial Hospital; Taipei Veterans General Hospital, Taiwan; National... and other collaborators

Terminated

Using Genetic Polymorphisms to Predict the Efficacy and Toxicity - A Gastric Adenocarcinoma Study

Gastric Adenocarcinoma

Taiwan
IRCCS Azienda Ospedaliero-Universitaria di Bologna

Completed

Preoperative Chemoradiation With VMAT-SIB in Rectal Cancer (GRACE)

Rectal Neoplasms
Wellstat Therapeutics

Approved for marketing

Uridine Triacetate as Antidote for Patients at Excess Risk of 5-FU Toxicity Due to Overdosage or Impaired Elimination

Toxicity Due to Chemotherapy
Cantonal Hospital of St. Gallen
University of Bern

Completed

Pharmacology-driven Dosing of Fluoropyrimidines in Cancer Patients (FLOXTOX2)

Colorectal Cancer

Switzerland
M.D. Anderson Cancer Center
National Cancer Institute (NCI); Pfizer

Terminated

Celecoxib in Preventing Hand/Foot Syndrome Caused By Capecitabine With Metastatic Breast or Colorectal Cancer

Pain | Breast Cancer | Colorectal Cancer

United States, Puerto Rico
Hoosier Cancer Research Network
United States Department of Defense; Indiana University School of Medicine; Walther...

Terminated

A Correlative Study for Predicting Response and Toxicity in Patients Receiving Chemotherapy for Breast Cancer

Breast Cancer

United States, Peru
National Cancer Centre, Singapore

Terminated

Pyridoxine in Preventing Hand-Foot Syndrome Caused by Capecitabine in Patients With Cancer

Unspecified Adult Solid Tumor, Protocol Specific | Palmar-plantar Erythrodysesthesia | Dermatologic Complications

Singapore
The Netherlands Cancer Institute

Completed

Pharmacogenomic and Pharmacokinetic Safety and Cost-saving Analysis in Patients Treated With Fluoropyrimidines

Neoplasms

Netherlands
University of Oxford
oxBRC; Vodafone UK Foundation; Centre for Statistics in Medicine; Oncology Clinical...

Completed

Dose Adaptation of Capecitabine Using Mobile Phone Toxicity Monitoring (DATACAP)

Metastatic Colorectal Cancer | Metastatic Breast Cancer

United Kingdom
Rabin Medical Center

Unknown

Prevention of Capecitabine Induced Hand and Foot Syndrome

Cancer

Israel
Royal Marsden NHS Foundation Trust

Completed

Phase II Trial Assessing Efficacy and Toxicity of Capecitabine and Oxaliplatin in the Treatment of Colorectal Cancer

Colorectal Cancer

United Kingdom
Nanjing Sike Pharmaceutical Co., Ltd.

Unknown

Dose Escalation Study of Liposomal Paclitaxel Plus Capecitabine in Chinese Patients With Advanced Gastric Carcinoma

Advanced Gastric Carcinoma
GlaxoSmithKline

Completed

Ispinesib In Combination With Capecitabine In Patients With Solid Tumors

Solid Tumor Cancer

United States
Fondazione Policlinico Universitario Agostino Gemelli...

Not yet recruiting

Evaluation of Ultraaccelerated High Dose Rate Intrauterine Interventional Radiotherapy (EROS3)

Locally Advanced Cervical Carcinoma
Beijing Hospital of Traditional Chinese Medicine

Not yet recruiting

A Multicentre Randomized Controlled Clinical Study on the Chitosan Nanocrystalline Qinteng Huoxue Runji Ointment Therapy for Psoriasis With Blood Stasis Syndrome.

Plaque Psoriasis
First Affiliated Hospital of Chengdu Medical College

Recruiting

Deep-sea Fish Oil for Prevention of Acute Radiation-induced Esophagitis

Esophageal Cancer | Esophagitis | Radiation Toxicity

China
Merck Sharp & Dohme LLC

Not yet recruiting

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR

Triple-Negative Breast Cancer
Fudan University
Shanghai Zhongshan Hospital; RenJi Hospital; First Hospital of China Medical... and other collaborators

Not yet recruiting

Organ Preservation With Tislelizumab and Total Neoadjuvant Therapy in Patients With Low Rectal Cancer: RELIEVE -01 Study

Rectal Cancer | RECTAL NEOPLASMS
Universitair Ziekenhuis Brussel
University Ghent; Vrije Universiteit Brussel

Not yet recruiting

Investigating Paclitaxel Toxicity in Breast Cancer: The Roles of Physical Activity and Body Composition. (PABTOX)

Breast Cancer | Body Weight | Chemotherapeutic Toxicity | Physical Inactivity | Chemotherapeutic Agent Toxicity | Paclitaxel Adverse Reaction

Belgium
Health Science Center of Xi'an Jiaotong University
Huazhong University of Science and Technology; LinkDoc Technology (Beijing)...

Not yet recruiting

Clinical Study of Huaier Granule in the Treatment of Unresectable Pancreatic Cancer

Pancreatic Cancer Non-resectable
Institute of Hematology & Blood Diseases Hospital...

Not yet recruiting

Efficacy and Safety of Low-dose Chemotherapy Plus Immuno-targeted Drugs in Newly Diagnosed Elderly/Unfit Ph- B-ALL

Precursor Cell Lymphoblastic Leukemia-Lymphoma
Hunan Cancer Hospital

Recruiting

Utidelone (UTD1) Plus Capecitabine in Non-pCR TNBC After Neoadjuvant Therapy

Triple Negative Breast Neoplasms

China
Assiut University

Not yet recruiting

Livertoxcicity in Acute Leukemia Patients During Chemotherapy Treatment

Liver Toxicity, Chemically-Induced
Shanghai Escugen Biotechnology Co., Ltd

Not yet recruiting

A Phase III Study of ESG401 for Locally Advanced or Metastatic HR+/HER2- Breast Cancer

Metastatic Breast Cancer

China
Washington University School of Medicine
American Academy of Clinical Toxicology

Not yet recruiting

Rivastigmine for Antimuscarinic Delirium (RIVA-AM)

Anticholinergic Toxicity

United States
Institut du Cancer de Montpellier - Val d'Aurelle

Not yet recruiting

Personalization of Breast Radiotherapy According to Loco-regional Recurrence Risk and Toxicity Probability (PROBA)

Breast Cancer

France
Sichuan Baili Pharmaceutical Co., Ltd.
Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.

Not yet recruiting

A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With Unresectable Locally Advanced or Metastatic Triple-Negative Breast Cancer

Triple-Negative Breast Cancer

China
Convalife (Shanghai) Co., Ltd.

Not yet recruiting

Nilatinib Maleate Tablets Combined With Capecitabine in the Treatment of HER2-positive Advanced Esophageal/Esophagogastric Junction/Gastric Adenocarcinoma With Brain Metastases

Her2-positive Advanced Esophageal/Esophagogastric Junction/Gastric Adenocarcinoma With Brain Metastasis
Washington University School of Medicine
United States Department of Defense; Aclaris Therapeutics, Inc.

Not yet recruiting

Zunsemetinib in Combination With Capecitabine in Patients With Hormone Receptor-Positive and HER2-Negative Metastatic Breast Cancer With Bone Metastasis

Hormone Receptor Positive HER-2 Negative Metastatic Breast Cancer

United States
Ruijin Hospital

Not yet recruiting

Neoadjuvant Chemotherapy Plus Sequential Immune Checkpoint Inhibitor (ICI) Therapy in Locally Advanced Colon Cancer (NeoCHIC)

Colon Cancer

China
ImmunoGen, Inc.

Not yet recruiting

A Study of Ocular Toxicity Evaluation and Mitigation During Treatment With Mirvetuximab Soravtansine in Participants With Recurrent Ovarian Cancer With High Folate Receptor-Alpha Expression

Recurrent Ovarian Cancer | Folate Receptor-Alpha Positive

United States, Spain, Australia, Belgium, Canada, France, Ireland, Italy

Search clinical trials for: capecitabine toxicity

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Gambia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations